COVID-19 Applications of Vagus Stimulation
Many patients hospitalized with COVID-19 predominantly die of organ failure due to a surge of pro-inflammatory molecules called cytokines. This in turn can trigger acute respiratory distress syndrome (ARDS) resulting in the need for mechanical ventilation. Known as a “cytokine storm”, the surge in cytokines is very much like the excessive inflammatory reaction associated with septic shock. Even after surviving the acute infection, many patients continue to struggle with prolonged effects from the damage left by the punishing surge of inflammation
Combating the Inflammatory Surge Associated with COVID-19
Drawing on his unique background as an HIV researcher and physician, combined with his present-day expertise in the use of vagus nerve stimulation (VNS) to regulate inflammation, Dr. Nemechek is working to develop a safe and effective therapy to assist patients in minimizing the damage from the inflammatory surge that can accompany COVID-19 infection.
Nemechek Technologies successes to date include:
- Sponsorship of a clinical trial show low mortality and mechanical ventilation in hospitalized COVID-19 patients treated with taVNS.
- Dr. Nemechek was recently awarded a U.S. PATENT for Methods of Treating COVID-19 Induced Cytokine Storm.
- We are presently in the prototype phase for the development of an FDA-approvable taVNS device.
- Submission of an Emergency Use Authorization (EUA) for taVNS as adjunctive therapy for hospitalized patients with acute symptoms of COVID-19.
- Seeking partnerships to conduct taVNS associated clinical trials.
Addressing the Needs of Long Haulers
Our company is designing a clinical study to address the challenges patients face during their recovery from COVID-19 infection. Know as “long haulers”, the chronic symptoms that remain after acute infection can be daunting.
Symptoms of fatigue, “brain fog”, confusion, thirst, labored breathing, headaches, lightheadedness, frequent urination are collectively suggestive for autonomic nervous system dysfunction. Dr. Nemechek has focused his last 15 years of research on developing techniques capable of reversing symptoms from autonomic damage.
His research culminated to being awarded a patent for “Methods of Reversing Autonomic Nervous System Damage” (US patent # 10,335,396), a safe a effective approach for treating autonomic nervous system dysfunction.
For those with chronic symptoms that appeared after COVID-19 infection, we are presently working towards:
Looking for Corporate Partners
Nemechek Technologies is a small company with cutting edge expertise and a clear vision of the medical needs of patients afflicted with COVID-19.
If you or your organization are interested in learning more about our efforts, please contact us through the contact form or by calling us directly.
We are looking for interested partners to fulfill our mission and make a difference in the lives of COVID-19 infected individuals.